a comparison of placebo , auranofin , and parenteral gold sodium thiomalate therapy in 209 patients with active rheumatoid arthritis was performed in a 21-week prospective , controlled , double-blind multicenter trial .
C0004320
auranofin
C0003873
rheumatoid arthritis